| Specialty Retail Industry | Consumer Discretionary Sector | Lynn Stockwell CEO | OTC PINK Exchange | 10920G100 CUSIP |
| US Country | 5 Employees | - Last Dividend | - Last Split | 17 May 2022 IPO Date |
Bright Green Corporation is a pioneering enterprise based in Grants, New Mexico, specializing in the production and export of legal cannabis and its derivatives. Since its inception in 2019, the company has committed itself to providing high-quality cannabis, cannabis extracts, and tetrahydrocannabinol (THC) across the United States. Catering to a wide range of needs, Bright Green Corporation supports research, manufacturing, and export efforts. Additionally, it plays a significant role in the production of medical cannabis products and preparations, demonstrating its commitment to improving health and well-being through natural, cannabis-based solutions.
Bright Green Corporation offers high-quality, legal cannabis cultivated under stringent regulations to ensure purity and efficacy. This product is intended for use in research, manufacturing, and medical applications, meeting the diverse needs of customers in accordance with legal standards.
The company provides a variety of cannabis extracts, which include concentrated forms of cannabinoids and terpenes extracted from the cannabis plant. These extracts are used in the development of pharmaceuticals, therapeutic products, and research applications, offering versatile solutions for both medical and industrial uses.
Bright Green Corporation specializes in the production and supply of THC, the psychoactive compound found in cannabis. THC is available for use in medical research, pharmaceutical development, and the manufacture of medical cannabis products, highlighting the company’s role in advancing cannabis-based medical solutions.
The company extends its product line to include specific medical cannabis products and preparations designed for patient use. These offerings are focused on providing relief for a variety of conditions, emphasizing the therapeutic benefits of cannabis while ensuring safety and compliance with healthcare regulations.